APIMEDS PHARMACEUTICALS US, INC. (APUS) Capital expenditures
APIMEDS PHARMACEUTICALS US, INC. (APUS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$57,333FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $57,333 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice